Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avik Dutta

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Blood|June 23, 2017
Hmga2 promotes the development of myelofibrosis in Jak2<sup>V617F</sup> knockin mice by enhancing TGF-β1 and Cxcl12 pathwaysAvik Dutta, Robert E Hutchison, Golam Mohi
Trends in Immunology|July 15, 2021
New insights into TCR β-selectionAvik Dutta, Bin Zhao, Paul E Love
Cells|December 24, 2021
New Insights into Epigenetic Regulation of T Cell DifferentiationAvik Dutta, Harini Venkataganesh, Paul E Love
International Reviews of Immunology|December 30, 2021
Epigenetic regulation of T cell developmentAvik Dutta, Harini Venkataganesh, Paul E Love
British Journal of Haematology|December 28, 2016
STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in miceAvik Dutta, Dongqing Yan, Robert E Hutchison, et al.
Trends in Immunology|April 2, 2026
THEMIS: new insights into its evolution, structure, and functionAvik Dutta, L Aravind, Seeyoung Choi, et al.
Blood Cancer Journal|November 27, 2023
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasmYue Yang, Salar Abbas, Mohammad A Sayem, et al.
Cancer Research|June 19, 2021
CDK6 Is a Therapeutic Target in MyelofibrosisAvik Dutta, Dipmoy Nath, Yue Yang, et al.
Leukemia|January 8, 2021
U2af1 is required for survival and function of hematopoietic stem/progenitor cellsAvik Dutta, Yue Yang, Bao T Le, et al.
Pharmaceutical Nanotechnology|October 22, 2025
Advancements in Carbon Nanotube-based Drug Delivery Systems: Innovations, Challenges, and Future DirectionsFaruk Alam, Prasurjya Saikia, Durgaprasad Kemisetti, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Blood|June 23, 2017
Hmga2 promotes the development of myelofibrosis in Jak2<sup>V617F</sup> knockin mice by enhancing TGF-β1 and Cxcl12 pathwaysAvik Dutta, Robert E Hutchison, Golam Mohi
Trends in Immunology|July 15, 2021
New insights into TCR β-selectionAvik Dutta, Bin Zhao, Paul E Love
Cells|December 24, 2021
New Insights into Epigenetic Regulation of T Cell DifferentiationAvik Dutta, Harini Venkataganesh, Paul E Love
International Reviews of Immunology|December 30, 2021
Epigenetic regulation of T cell developmentAvik Dutta, Harini Venkataganesh, Paul E Love
British Journal of Haematology|December 28, 2016
STAT3 mutations are not sufficient to induce large granular lymphocytic leukaemia in miceAvik Dutta, Dongqing Yan, Robert E Hutchison, et al.
Trends in Immunology|April 2, 2026
THEMIS: new insights into its evolution, structure, and functionAvik Dutta, L Aravind, Seeyoung Choi, et al.
Blood Cancer Journal|November 27, 2023
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasmYue Yang, Salar Abbas, Mohammad A Sayem, et al.
Cancer Research|June 19, 2021
CDK6 Is a Therapeutic Target in MyelofibrosisAvik Dutta, Dipmoy Nath, Yue Yang, et al.
Leukemia|January 8, 2021
U2af1 is required for survival and function of hematopoietic stem/progenitor cellsAvik Dutta, Yue Yang, Bao T Le, et al.
Pharmaceutical Nanotechnology|October 22, 2025
Advancements in Carbon Nanotube-based Drug Delivery Systems: Innovations, Challenges, and Future DirectionsFaruk Alam, Prasurjya Saikia, Durgaprasad Kemisetti, et al.
Pageof 2